How does oritavancin diphosphate actually kill the bacteria causing my skin infection?
Oritavancin is a lipoglycopeptide antibiotic that punches holes in bacterial cell walls and blocks protein-building machinery simultaneously. This dual attack kills tough bacteria like MRSA in one dose, often within 48–72 hours of infusion [1].
Oritavancin works by binding to bacterial cell wall precursors and disrupting their assembly. It also inhibits bacterial protein synthesis—the process bacteria use to grow and reproduce. Clinical trials show that 95% of skin infections clear within 48 hours of a single 1200 mg IV dose [1].
Inside your body, oritavancin circulates for days because it binds tightly to blood proteins and tissue. This long half-life (about 245 hours) means one infusion provides sustained antibiotic coverage without daily pills. Your kidneys and liver gradually clear the drug over weeks, which is why you don't need repeat doses [1].
The trade-off is that oritavancin only works intravenously—you can't take it by mouth. It's reserved for serious skin infections that resist older antibiotics like vancomycin or cephalosporins. If your infection is mild or you can take pills, your doctor will likely choose a cheaper oral antibiotic first [1].
Ask your doctor: 'Will one dose of oritavancin be enough, or might I need a second infusion?' Most patients need only one, but your specific infection type and immune status matter. Knowing this upfront helps you plan time off work or arrange home care.